Correlation Between Zivo Bioscience and Structure Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zivo Bioscience and Structure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zivo Bioscience and Structure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zivo Bioscience and Structure Therapeutics American, you can compare the effects of market volatilities on Zivo Bioscience and Structure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zivo Bioscience with a short position of Structure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zivo Bioscience and Structure Therapeutics.
Diversification Opportunities for Zivo Bioscience and Structure Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Zivo and Structure is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Zivo Bioscience and Structure Therapeutics America in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Structure Therapeutics and Zivo Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zivo Bioscience are associated (or correlated) with Structure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Structure Therapeutics has no effect on the direction of Zivo Bioscience i.e., Zivo Bioscience and Structure Therapeutics go up and down completely randomly.
Pair Corralation between Zivo Bioscience and Structure Therapeutics
Given the investment horizon of 90 days Zivo Bioscience is expected to under-perform the Structure Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Zivo Bioscience is 1.12 times less risky than Structure Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Structure Therapeutics American is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 2,370 in Structure Therapeutics American on November 2, 2024 and sell it today you would earn a total of 685.00 from holding Structure Therapeutics American or generate 28.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 22.67% |
| Values | Daily Returns |
Zivo Bioscience vs. Structure Therapeutics America
Performance |
| Timeline |
| Zivo Bioscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Structure Therapeutics |
Zivo Bioscience and Structure Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zivo Bioscience and Structure Therapeutics
The main advantage of trading using opposite Zivo Bioscience and Structure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zivo Bioscience position performs unexpectedly, Structure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will offset losses from the drop in Structure Therapeutics' long position.| Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |